Insider Trading & SAST disclosures for Nephro Care India Ltd.
There were no Insider Trade disclosures made for Nephro Care India Ltd.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Pratim Sengupta in Nephro Care India Ltd. where Acquisition of 8,800
Equity shares done
was reported to the exchange on Jan. 17, 2025.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
|
Pratim Sengupta
|
Promoter |
Acquisition |
18 Jan 2025 |
8,800 |
10,008,800
|
-
|
|
-
|
15 Jan 2025
15 Jan 2025 |
SAST (Reg29(2)) |
Equity shares |
Open Market |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.